Polydatin enhances oxaliplatin-induced cell death by activating NOX5-ROS-mediated DNA damage and ER stress in colon cancer cells
The combination of PD and OXA could be an effective treatment strategy for certain patients with CRC.
Authors
- Chenguo Zheng (ORCID: https://orcid.org/0000-0003-0330-9495)
- Ri Cui (ORCID: https://orcid.org/0000-0001-6202-8779)
- Annabeth Onga
- Tao Zhang (ORCID: https://orcid.org/0000-0001-6643-4686)
- Namki Cho (ORCID: https://orcid.org/0000-0002-9936-3463)
- Jieyu Liu (ORCID: https://orcid.org/0000-0001-8550-7676)
- Peipei Chen (ORCID: https://orcid.org/0009-0008-3200-3173)
- Qi Zhao (ORCID: https://orcid.org/0000-0001-9072-1052)
Institutions
- Chonnam National University (KR)
- Wenzhou Medical University (CN)
- Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-01-09
- DOI
- https://doi.org/10.3389/fphar.2024.1532695
- Citations
- 2
- Primary Topic
- Bioactive Compounds and Antitumor Agents
- Type
- article
- Field-Weighted Citation Impact
- 2.61
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province